Evidence map›Paper›PMID 8666429›Full record

ArticleImmunology1996

Identification of interleukin-2 in human peripheral blood eosinophils.

F Levi-Schaffer, J Barkans, T M Newman, S Ying, M Wakelin, R Hohenstein, V Barak, P Lacy, A B Kay, R Moqbel

Open access · greenAbstract read
In one paragraph

Article in Immunology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 85 citations in OpenAlex.

  1. Eosinophils and melanoma: Implications for immunotherapy.Pigment cell & melanoma research · 2022
    Review
  2. Article
  3. Review
  4. Eosinophils in human oral squamous carcinoma; role of prostaglandin D2.Journal of inflammation (London, England) · 2013
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Immunoregulatory roles of eosinophils: a new look at a familiar cell.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2008
    Review
  11. Review
  12. Article
  13. Cytokines in asthma.Thorax · 1999
    Review
  14. Article
  15. Article
  16. Evaluation of myeloid cells (tumor-associated tissue eosinophils and mast cells) infiltration in different grades of oral squamous cell carcinoma.Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

F Levi-SchafferDepartment of Allergy and Clinical Immunology, National Heart and Lung Institute, London, UK.
J Barkans
T M Newman
S Ying
M Wakelin
R Hohenstein
V Barak
P Lacy
A B Kay
R Moqbel

Funding

Wellcome Trust
6 · The paper itself

Abstract

Interleukin-2 (IL-2) is an essential growth factor for T cells. Previous studies have shown that human peripheral eosinophils respond to IL-2 in chemotaxis and express the IL-2 receptor (CD25). In addition, eosinophils have been shown to transcribe messenger RNA for IL-2. The aim of the present study was to determine whether eosinophils translate mRNA for IL-2 and to determine the site of intracellular localization. By immunocytochemistry, an average of 9% of cells showed cytoplasmic staining for IL-2 in freshly isolated unstimulated blood eosinophils obtained from asthmatic subjects who were not receiving oral corticosteroid treatment (n = 5). Freshly isolated, disrupted, highly purified eosinophils (> 99%, by CD16- immunomagnetic selection) contained an average of 6 pg/10(6) cells of IL-2 measured by a specific enzyme linked immunosorbent assay (ELISA) (n = 7). Purified eosinophil incubated with serum-coated Sephadex beads showed an increase in the amount of intracellularly-retained IL-2 (26.2 +/- 7.2 pg/10(6) cells) with some evidence for release of this cytokine but only in three out of six eosinophil preparations (range 1.3-5.8 pg/10(6) cells). The intracellular localization of IL-2 was determined by fractionation of the cells on a linear (0-45%) Nycodenz gradient in sucrose buffer followed by detection of IL-2 in the fractions using an IL-2-specific ELISA and dot blotting. The majority of the IL-2 detected co-eluted with known eosinophil granule markers (i.e. major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO) and beta-hexosaminidase) but small quantities were also detected in the cytosolic (lactate dehydrogenase-(LDH) associated) and membrane (CD9+) fractions. Immunogold labelling of intact eosinophils using an anti-IL-2 monoclonal antibody confirmed IL-2 immunoreactivity in association with the eosinophil crystalline granule cores. These data are consistent with the hypothesis that eosinophils synthesize, release and store IL-2 largely within cystalloid granules. This stored IL-2 may serve as a reservoir for rapid release of IL-2 in inflammatory reactions associated with eosinophilia.

Indexed as

AsthmaCell FractionationCytoplasmic GranulesEosinophilsHumansImmunoblottingImmunoenzyme TechniquesInterleukin-2Microscopy, ImmunoelectronInterleukin-2

Identifiers

PMID8666429
PMCPMC1383982
OpenAlexW1495604605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.